nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Cough increased—Epirubicin—liver cancer	0.00438	0.00438	CcSEcCtD
Meropenem—Glossitis—Epirubicin—liver cancer	0.00435	0.00435	CcSEcCtD
Meropenem—Angioedema—Sorafenib—liver cancer	0.00433	0.00433	CcSEcCtD
Meropenem—Delirium—Doxorubicin—liver cancer	0.00431	0.00431	CcSEcCtD
Meropenem—Syncope—Sorafenib—liver cancer	0.00425	0.00425	CcSEcCtD
Meropenem—Leukopenia—Sorafenib—liver cancer	0.00424	0.00424	CcSEcCtD
Meropenem—Blood bilirubin increased—Epirubicin—liver cancer	0.00424	0.00424	CcSEcCtD
Meropenem—Jaundice cholestatic—Doxorubicin—liver cancer	0.00422	0.00422	CcSEcCtD
Meropenem—Creatinine increased—Epirubicin—liver cancer	0.00421	0.00421	CcSEcCtD
Meropenem—Loss of consciousness—Sorafenib—liver cancer	0.00417	0.00417	CcSEcCtD
Meropenem—Cough—Sorafenib—liver cancer	0.00414	0.00414	CcSEcCtD
Meropenem—Inflammation—Epirubicin—liver cancer	0.00413	0.00413	CcSEcCtD
Meropenem—Hypertension—Sorafenib—liver cancer	0.00409	0.00409	CcSEcCtD
Meropenem—Cough increased—Doxorubicin—liver cancer	0.00405	0.00405	CcSEcCtD
Meropenem—Glossitis—Doxorubicin—liver cancer	0.00402	0.00402	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00401	0.00401	CcSEcCtD
Meropenem—Vaginal inflammation—Epirubicin—liver cancer	0.00401	0.00401	CcSEcCtD
Meropenem—Pulmonary embolism—Epirubicin—liver cancer	0.00401	0.00401	CcSEcCtD
Meropenem—Injection site reaction—Epirubicin—liver cancer	0.00398	0.00398	CcSEcCtD
Meropenem—Blood bilirubin increased—Doxorubicin—liver cancer	0.00392	0.00392	CcSEcCtD
Meropenem—Melaena—Epirubicin—liver cancer	0.00391	0.00391	CcSEcCtD
Meropenem—Creatinine increased—Doxorubicin—liver cancer	0.00389	0.00389	CcSEcCtD
Meropenem—Anaphylactic shock—Sorafenib—liver cancer	0.00387	0.00387	CcSEcCtD
Meropenem—Colitis—Epirubicin—liver cancer	0.00385	0.00385	CcSEcCtD
Meropenem—Infection—Sorafenib—liver cancer	0.00384	0.00384	CcSEcCtD
Meropenem—Candida infection—Epirubicin—liver cancer	0.00383	0.00383	CcSEcCtD
Meropenem—Inflammation—Doxorubicin—liver cancer	0.00382	0.00382	CcSEcCtD
Meropenem—Shock—Sorafenib—liver cancer	0.00381	0.00381	CcSEcCtD
Meropenem—Nervous system disorder—Sorafenib—liver cancer	0.00379	0.00379	CcSEcCtD
Meropenem—Thrombocytopenia—Sorafenib—liver cancer	0.00379	0.00379	CcSEcCtD
Meropenem—Blood urea increased—Epirubicin—liver cancer	0.00378	0.00378	CcSEcCtD
Meropenem—Vaginal infection—Epirubicin—liver cancer	0.00378	0.00378	CcSEcCtD
Meropenem—Neuropathy—Epirubicin—liver cancer	0.00376	0.00376	CcSEcCtD
Meropenem—Skin disorder—Sorafenib—liver cancer	0.00376	0.00376	CcSEcCtD
Meropenem—Vaginal inflammation—Doxorubicin—liver cancer	0.00371	0.00371	CcSEcCtD
Meropenem—Pulmonary embolism—Doxorubicin—liver cancer	0.00371	0.00371	CcSEcCtD
Meropenem—Anorexia—Sorafenib—liver cancer	0.00369	0.00369	CcSEcCtD
Meropenem—Injection site reaction—Doxorubicin—liver cancer	0.00369	0.00369	CcSEcCtD
Meropenem—Melaena—Doxorubicin—liver cancer	0.00362	0.00362	CcSEcCtD
Meropenem—Pulmonary oedema—Epirubicin—liver cancer	0.00357	0.00357	CcSEcCtD
Meropenem—Colitis—Doxorubicin—liver cancer	0.00356	0.00356	CcSEcCtD
Meropenem—Candida infection—Doxorubicin—liver cancer	0.00354	0.00354	CcSEcCtD
Meropenem—Vaginal infection—Doxorubicin—liver cancer	0.0035	0.0035	CcSEcCtD
Meropenem—Blood urea increased—Doxorubicin—liver cancer	0.0035	0.0035	CcSEcCtD
Meropenem—Neuropathy—Doxorubicin—liver cancer	0.00348	0.00348	CcSEcCtD
Meropenem—Sepsis—Epirubicin—liver cancer	0.00348	0.00348	CcSEcCtD
Meropenem—Dyspnoea—Sorafenib—liver cancer	0.00345	0.00345	CcSEcCtD
Meropenem—Dyspepsia—Sorafenib—liver cancer	0.00341	0.00341	CcSEcCtD
Meropenem—Phlebitis—Epirubicin—liver cancer	0.00338	0.00338	CcSEcCtD
Meropenem—Decreased appetite—Sorafenib—liver cancer	0.00336	0.00336	CcSEcCtD
Meropenem—Thrombophlebitis—Epirubicin—liver cancer	0.00336	0.00336	CcSEcCtD
Meropenem—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00334	0.00334	CcSEcCtD
Meropenem—Gastrointestinal disorder—Sorafenib—liver cancer	0.00334	0.00334	CcSEcCtD
Meropenem—Pain—Sorafenib—liver cancer	0.00331	0.00331	CcSEcCtD
Meropenem—Constipation—Sorafenib—liver cancer	0.00331	0.00331	CcSEcCtD
Meropenem—Pulmonary oedema—Doxorubicin—liver cancer	0.0033	0.0033	CcSEcCtD
Meropenem—Hepatic failure—Epirubicin—liver cancer	0.00324	0.00324	CcSEcCtD
Meropenem—Sepsis—Doxorubicin—liver cancer	0.00322	0.00322	CcSEcCtD
Meropenem—Gastrointestinal pain—Sorafenib—liver cancer	0.00316	0.00316	CcSEcCtD
Meropenem—Phlebitis—Doxorubicin—liver cancer	0.00312	0.00312	CcSEcCtD
Meropenem—Thrombophlebitis—Doxorubicin—liver cancer	0.00311	0.00311	CcSEcCtD
Meropenem—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00309	0.00309	CcSEcCtD
Meropenem—Urticaria—Sorafenib—liver cancer	0.00307	0.00307	CcSEcCtD
Meropenem—Abdominal pain—Sorafenib—liver cancer	0.00306	0.00306	CcSEcCtD
Meropenem—Body temperature increased—Sorafenib—liver cancer	0.00306	0.00306	CcSEcCtD
Meropenem—Hepatic failure—Doxorubicin—liver cancer	0.00299	0.00299	CcSEcCtD
Meropenem—Hypoglycaemia—Epirubicin—liver cancer	0.00298	0.00298	CcSEcCtD
Meropenem—Cardiac failure—Epirubicin—liver cancer	0.00298	0.00298	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00291	0.00291	CcSEcCtD
Meropenem—Hypersensitivity—Sorafenib—liver cancer	0.00285	0.00285	CcSEcCtD
Meropenem—Asthenia—Sorafenib—liver cancer	0.00278	0.00278	CcSEcCtD
Meropenem—Cardiac arrest—Epirubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Meropenem—Hypoglycaemia—Doxorubicin—liver cancer	0.00276	0.00276	CcSEcCtD
Meropenem—Cardiac failure—Doxorubicin—liver cancer	0.00276	0.00276	CcSEcCtD
Meropenem—Pruritus—Sorafenib—liver cancer	0.00274	0.00274	CcSEcCtD
Meropenem—Blood creatinine increased—Epirubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00269	0.00269	CcSEcCtD
Meropenem—Hypokalaemia—Epirubicin—liver cancer	0.00265	0.00265	CcSEcCtD
Meropenem—Diarrhoea—Sorafenib—liver cancer	0.00265	0.00265	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00262	0.00262	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00262	0.00262	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00257	0.00257	CcSEcCtD
Meropenem—Cardiac arrest—Doxorubicin—liver cancer	0.00256	0.00256	CcSEcCtD
Meropenem—Dizziness—Sorafenib—liver cancer	0.00256	0.00256	CcSEcCtD
Meropenem—Abdominal distension—Epirubicin—liver cancer	0.00253	0.00253	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—liver cancer	0.00252	0.00252	CcSEcCtD
Meropenem—Asthma—Epirubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Meropenem—Eosinophilia—Epirubicin—liver cancer	0.00249	0.00249	CcSEcCtD
Meropenem—Vomiting—Sorafenib—liver cancer	0.00246	0.00246	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—liver cancer	0.00245	0.00245	CcSEcCtD
Meropenem—Rash—Sorafenib—liver cancer	0.00244	0.00244	CcSEcCtD
Meropenem—Dermatitis—Sorafenib—liver cancer	0.00244	0.00244	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Meropenem—Headache—Sorafenib—liver cancer	0.00242	0.00242	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00237	0.00237	CcSEcCtD
Meropenem—Dysuria—Epirubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—liver cancer	0.00234	0.00234	CcSEcCtD
Meropenem—Asthma—Doxorubicin—liver cancer	0.00233	0.00233	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—liver cancer	0.0023	0.0023	CcSEcCtD
Meropenem—Nausea—Sorafenib—liver cancer	0.0023	0.0023	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—liver cancer	0.00225	0.00225	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Meropenem—Infestation—Epirubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Meropenem—Renal failure—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Meropenem—Jaundice—Epirubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Meropenem—Sweating—Epirubicin—liver cancer	0.00215	0.00215	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—liver cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—liver cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—liver cancer	0.00207	0.00207	CcSEcCtD
Meropenem—Infestation—Doxorubicin—liver cancer	0.00207	0.00207	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00206	0.00206	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—liver cancer	0.00205	0.00205	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—liver cancer	0.002	0.002	CcSEcCtD
Meropenem—Sweating—Doxorubicin—liver cancer	0.00199	0.00199	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—liver cancer	0.00198	0.00198	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—liver cancer	0.00185	0.00185	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—liver cancer	0.00182	0.00182	CcSEcCtD
Meropenem—Chills—Epirubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Meropenem—Erythema—Epirubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Meropenem—Flatulence—Epirubicin—liver cancer	0.00173	0.00173	CcSEcCtD
Meropenem—Tension—Epirubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Meropenem—Nervousness—Epirubicin—liver cancer	0.0017	0.0017	CcSEcCtD
Meropenem—Back pain—Epirubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Meropenem—Chills—Doxorubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Meropenem—Erythema—Doxorubicin—liver cancer	0.00162	0.00162	CcSEcCtD
Meropenem—Anaemia—Epirubicin—liver cancer	0.00162	0.00162	CcSEcCtD
Meropenem—Agitation—Epirubicin—liver cancer	0.00161	0.00161	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Meropenem—Tension—Doxorubicin—liver cancer	0.00159	0.00159	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—liver cancer	0.00159	0.00159	CcSEcCtD
Meropenem—Malaise—Epirubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Syncope—Epirubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Back pain—Doxorubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—liver cancer	0.00154	0.00154	CcSEcCtD
Meropenem—Cough—Epirubicin—liver cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Hypertension—Epirubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—liver cancer	0.0015	0.0015	CcSEcCtD
Meropenem—Chest pain—Epirubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Agitation—Doxorubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Anxiety—Epirubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Meropenem—Malaise—Doxorubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Meropenem—Syncope—Doxorubicin—liver cancer	0.00145	0.00145	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—liver cancer	0.00145	0.00145	CcSEcCtD
Meropenem—Confusional state—Epirubicin—liver cancer	0.00144	0.00144	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—liver cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Oedema—Epirubicin—liver cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—liver cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Infection—Epirubicin—liver cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Cough—Doxorubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Meropenem—Shock—Epirubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Meropenem—Anorexia—Epirubicin—liver cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Hypotension—Epirubicin—liver cancer	0.00134	0.00134	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—liver cancer	0.00133	0.00133	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Meropenem—Oedema—Doxorubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Meropenem—Infection—Doxorubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Meropenem—Shock—Doxorubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Insomnia—Epirubicin—liver cancer	0.00129	0.00129	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—liver cancer	0.00129	0.00129	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Somnolence—Epirubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Meropenem—Pain—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Meropenem—Constipation—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—liver cancer	0.00119	0.00119	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—liver cancer	0.00116	0.00116	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Urticaria—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Pain—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Meropenem—Constipation—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—liver cancer	0.00109	0.00109	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Asthenia—Epirubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Pruritus—Epirubicin—liver cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—liver cancer	0.000978	0.000978	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—liver cancer	0.000975	0.000975	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—liver cancer	0.000949	0.000949	CcSEcCtD
Meropenem—Dizziness—Epirubicin—liver cancer	0.000945	0.000945	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—liver cancer	0.000936	0.000936	CcSEcCtD
Meropenem—Vomiting—Epirubicin—liver cancer	0.000909	0.000909	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—liver cancer	0.000905	0.000905	CcSEcCtD
Meropenem—Rash—Epirubicin—liver cancer	0.000901	0.000901	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—liver cancer	0.000901	0.000901	CcSEcCtD
Meropenem—Headache—Epirubicin—liver cancer	0.000896	0.000896	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—liver cancer	0.000875	0.000875	CcSEcCtD
Meropenem—Nausea—Epirubicin—liver cancer	0.000849	0.000849	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—liver cancer	0.000841	0.000841	CcSEcCtD
Meropenem—Rash—Doxorubicin—liver cancer	0.000834	0.000834	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—liver cancer	0.000833	0.000833	CcSEcCtD
Meropenem—Headache—Doxorubicin—liver cancer	0.000829	0.000829	CcSEcCtD
Meropenem—Nausea—Doxorubicin—liver cancer	0.000786	0.000786	CcSEcCtD
